There's all sorts of stuff they have alluded to and even flat out stated over the years that has never seen a further mention. Eg. PD1 synergy in lung.
I tried to have ChatGPT revisit every RAC announcement since 2020 that included a "Next Steps" section to put together a checklist but it wasn't playing ball. Might just manually go through these this week.
There was a slight language change regarding MOA publication in the most recent investor publication. Until this point they'd only spoken to the 'new' cardioprotective MOA and FTO/m6A. Perhaps this is why we STILL haven't seen anything on CPACS. With the exception of the MOPACS soft launch; there's been nothing new published on Zan for some ~3 years.
There's obviously (at least) 3 distinct functions they are looking at, the delay probably has something to do with this.
(20min delay)